MARKET

ANIX

ANIX

Anixa Biosciences Inc
NASDAQ
2.550
-0.170
-6.25%
After Hours: 2.680 +0.13 +5.10% 19:52 04/02 EDT
OPEN
2.690
PREV CLOSE
2.720
HIGH
2.760
LOW
2.550
VOLUME
70.02K
TURNOVER
--
52 WEEK HIGH
5.46
52 WEEK LOW
2.331
MARKET CAP
85.50M
P/E (TTM)
-8.0927
1D
5D
1M
3M
1Y
5Y
1D
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks · 1d ago
BUZZ-Anixa Biosciences climbs after breast cancer vaccine moves to mid-stage trial
Reuters · 2d ago
Anixa Biosciences announces agreement with Cytovance Biologics
TipRanks · 2d ago
Anixa Biosciences Enters Into Development And Manufacturing Agreement With Cytovance Biologics To Produce cGMP Clinical Materials For Planned Phase 2 Clinical Trial Of Breast Cancer Vaccine
Benzinga · 2d ago
Anixa advances breast cancer vaccine toward Phase 2 after positive Phase 1 data
Reuters · 2d ago
ANIXA BIOSCIENCES INC: PHASE 1 STUDY MET PRIMARY ENDPOINTS, SHOWED SAFETY AND TOLERABILITY AT MAXIMUM TOLERATED DOSE
Reuters · 2d ago
Anixa Biosciences Is Maintained at Buy by D. Boral Capital
Dow Jones · 3d ago
BUZZ-Anixa rises after lining up update on ovarian cancer therapy trial
Reuters · 4d ago
More
About ANIX
Anixa Biosciences, Inc. is a clinical-stage biotechnology company focused on the treatment and prevention of cancer. The Company's therapeutic portfolio consists of an ovarian cancer immunotherapy program being developed in collaboration with Moffitt Cancer Center, which uses a novel type of CAR-T, known as chimeric endocrine receptor-T cell (CER-T) technology. The Company's vaccine portfolio includes vaccines being developed in collaboration with Cleveland Clinic to treat and prevent breast cancer and ovarian cancer, as well as additional cancer vaccines to address many intractable cancers, including high incidence malignancies in lung, colon, and prostate. The Company is engaged in the development of vaccines for the treatment or prevention of triple negative breast cancer and other breast cancers which express the a-lactalbumin protein. Its vaccine technologies are focused on immunizing against retired proteins that have been found to be expressed in certain forms of cancer.

Webull offers Anixa Biosciences Inc stock information, including NASDAQ: ANIX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ANIX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ANIX stock methods without spending real money on the virtual paper trading platform.